(S1 (S (NP (NP (NN Effect)) (PP (IN of) (NP (NN 1-alkylpyrrolidine) (NNS N-oxides))) (PP (IN on) (NP (NP (NN energy) (NN metabolism)) (PP (IN of) (NP (NN cancer) (NNS cells))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ main) (NN purpose)) (PP (IN of) (NP (DT the) (JJ present) (NN investigation)))) (VP (VBD was) (S (VP (TO to) (VP (VB study) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT a) (JJ homologous) (NN series)) (PP (IN of) (NP (NN 1-alkylpyrrolidine) (NN N-oxides))))) (PP (IN on) (NP (NP (JJ ATP-producing) (NNS processes)) (PP (IN in) (NP (NP (NN Ehrlich) (NNS ascites)) (CC and) (NP (NN L1210) (JJ murine) (NN leukemia) (NNS cells)))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN on) (NP (NP (JJ aerobic) (NN glucose) (NN consumption)) (, ,) (NP (NP (JJ lactic) (NN acid)) (NN formation)) (, ,) (NP (NP (NN content)) (PP (IN of) (NP (NP (JJ total) (-LRB- -LRB-) (NN T-SH) (-RRB- -RRB-) (CC and) (NN non-protein) (NN thiol) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN NP-SH)) (-RRB- -RRB-))))) (, ,) (NP (JJ endogenous) (NN respiration)) (CC and) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN ATP)))))) (PP (IN in) (NP (NP (NN tumor) (NNS cells)) (VP (VBN incubated) (ADVP (FW in) (FW vitro)))))) (VP (VBD was) (VP (VBN investigated)))) (. .)))
(S1 (S (NP (NP (NP (JJ 1-Tetradecylpyrrolidine) (NN N-oxide)) (PRN (-LRB- -LRB-) (NP (NN TPNO)) (-RRB- -RRB-))) (, ,) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (JJS most) (JJ active) (NNS compounds)))) (, ,)) (PP (ADVP (RB immediately)) (IN after) (NP (NP (NN addition)) (PP (TO to) (NP (NP (DT the) (NN suspension)) (PP (IN of) (NP (NN Ehrlich) (NNS cells))) (PP (IN in) (NP (DT an) (NN ice) (NN bath))))))) (, ,) (VP (VBD decreased) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN ATP))) (PP (TO to) (NP (DT the) (JJ same) (NN extent)))) (PP (IN over) (NP (DT the) (JJ whole) (NN concentration) (NN range)))) (. .)))
(S1 (S (S (PP (IN After) (NP (NP (CD 2) (NN h) (NN incubation)) (PP (IN at) (NP (CD 37) (NNS degrees) (NN C))))) (NP (NP (DT the) (NN drop)) (PP (IN in) (NP (DT the) (NN ATP) (NN level)))) (VP (VBD was) (ADJP (JJR lower)))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN decrease)) (PP (IN in) (NP (NN ATP) (NN level)))) (VP (MD might) (VP (VB be) (VP (VBN explained) (PP (IN through) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN amine) (NN oxide))) (PP (IN with) (NP (DT the) (NN cell) (NN membrane) (NN integrity))))))))) (. .)))
